Cargando…
Safety, efficacy, and patient acceptability of imiquimod for topical treatment of actinic keratoses
Imiquimod, an immune-modulating imidazoquinoline compound, has been approved in topical formulation for the treatment of actinic keratoses, superficial basal cell carcinomas, and external genital warts. Its use in the treatment of field cancerization, in particular, has been rapidly evolving. With t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3114604/ https://www.ncbi.nlm.nih.gov/pubmed/21691565 http://dx.doi.org/10.2147/CCID.S14109 |